Name: Buy SR9009 10mg 50 Tablets | SARM Research Tablets
SKU: FB39
Price: 88.20 CAD
Availability: InStock
Rating: 4.00 (1 reviews)

SR9009 10mg - 50 Tablets

★★★★☆ 4.0 · 1 review SKU FB39

$88.20

In stock — dispatches within 24h, tracked

SR9009 10mg is a Rev-Erb agonist oral tablet formulation supplied in a 50 tablet pack. Manufactured for consistent potency, stability, and research applications.

Pay with Interac e-Transfer or Crypto

Ships from within Canada; No Customs

Discreet plain packaging; always

24h dispatch; Tracked Delivery

SR9009, commonly known as Stenabolic, is a synthetic Rev ErbA agonist and while frequently grouped alongside SARMs in research product categorization, it is mechanistically unrelated to androgen receptor activity entirely, operating instead through nuclear receptor modulation of the circadian clock and metabolic gene expression pathways. F40 Biotech’s formulation delivers 10mg per tablet in a 50 count format, consistent with the concentration most commonly referenced in Rev ErbA agonist preclinical research literature.

Rev ErbA is a nuclear receptor that functions as a core component of the molecular circadian clock, repressing the transcription of genes involved in lipid and glucose metabolism, mitochondrial biogenesis, and inflammatory pathways on a circadian rhythm dependent schedule. SR9009’s agonist activity at Rev ErbA produces effects that mimic and amplify this natural repressive transcriptional activity. Research has documented its influence on increasing mitochondrial number and oxidative metabolism in skeletal muscle, reducing adipogenesis, and modulating macrophage inflammatory activity in preclinical models. This mechanism is entirely distinct from every SARM, anabolic steroid, and growth hormone secretagogue in CSD’s range; SR9009 does not interact with the androgen receptor, estrogen receptor, or growth hormone axis in any capacity, making it a frequently misunderstood compound that is more accurately classified alongside metabolic research compounds like 5-Amino-1MQ and SLU-PP-332 than alongside true SARMs.

SR9009’s research profile is most extensively documented in metabolic and circadian biology literature, studies examining its effects on mitochondrial biogenesis, oxidative metabolism, and the circadian regulation of lipid and glucose homeostasis represent the primary preclinical research base for this compound. Its mechanism of nuclear receptor mediated transcriptional repression distinguishes it from receptor binding hormone analogues, positioning it as a unique tool for research examining the intersection of circadian biology and metabolic regulation independent of the androgen or growth hormone signaling pathways studied elsewhere in CSD’s range.

F40 Biotech formulations are stocked by Canada Steroid Depot following the same rigorous third party lab verification process applied to every product in our range. Each batch is tested for concentration accuracy and purity before being made available, with COA documentation available on request. CSD’s sourcing standards apply uniformly across all manufacturers we carry, and F40 Biotech’s SR9009 meets those standards consistently. All orders ship discreetly across Canada in plain, unmarked packaging with no identifying information on the exterior.

Store in a cool, dry place away from direct light and heat. Intended for research purposes only.

Commonly researched alongside SLU-PP-332 and 5-Amino-1MQ in comparative metabolic and mitochondrial regulation studies. Browse CSD’s full SARM and metabolic research range for complete sourcing.